Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: Intratumoral molecular heterogeneity

被引:0
|
作者
Zborovskaya, I
Gasparian, A
Karseladze, A
Elcheva, T
Trofimova, E
Driouch, K
Trassard, M
Tatosyan, A
Lidereau, R [1 ]
机构
[1] Ctr Rene Huguenin, F-92211 St Cloud, France
[2] Russian Acad Med Sci, Canc Res Ctr, Lab Oncogene Regulat, Moscow, Russia
[3] Ctr Rene Huguenin, St Cloud, France
关键词
D O I
10.1002/(SICI)1097-0215(19990909)82:6<822::AID-IJC9>3.0.CO;2-I
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Loss of heterozygosity (LOH) affects a number of chromosome regions in ovarian cancer, pointing to the possible involvement of tumour-suppressor genes in ovarian tumorigenesis. We performed comparative analysis of allelic loss at 6 frequently affected chromosome regions in a panel of 53 benign, borderline and malignant ovarian tumours. Precursor lesions could provide evidence that an accumulation of genetic events is required for normal ovarian epithelium to generate malignant tumours. LOH on chromosome Ip was relatively common in benign, borderline and malignant tumours, while at 11p and 7q it was observed not only in invasive but also in borderline tumours. Moreover, 17q and 18q were affected mainly in advanced malignant tumours and revealed a high frequency of clonal intratumoral heterogeneity. We encountered different spectra of genetic alterations in primary tumours and their metastasis, which may be the results of intratumoral heterogeneity leading to dissemination in only some sub-clones. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:822 / 826
页数:5
相关论文
共 50 条
  • [1] Multiple genetic alterations in ovarian tumors: a molecular intratumoral heterogeneity
    Elcheva, I
    Bogatyrev, V
    Panichenko, I
    Zborovskaya, I
    ANNALS OF ONCOLOGY, 2005, 16 : 296 - 296
  • [2] Genetic alterations in ovarian borderline tumours and ovarian carcinomas
    Schuyer, M
    Henzen-Logmans, SC
    van der Burg, MEL
    Fieret, JH
    Derksen, C
    Look, MP
    Meijer-van Gelder, ME
    Klijn, JGM
    Foekens, JA
    Berns, EMJJ
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1999, 82 (02): : 147 - 150
  • [3] Molecular genetic analysis of intratumoral TP53 heterogeneity in human astrocytic tumours
    Olofsson, T
    Ren, ZP
    Qu, M
    Hesselager, G
    Smits, A
    Nistér, M
    Kalimo, H
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2006, 32 (02) : 230 - 231
  • [4] Genetic alterations in benign and borderline malignant breast tumors
    DalCin, P
    Christiaens, MR
    Bullerdiek, J
    VandenBerghe, H
    Moerman, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 12 - 12
  • [5] Molecular portraits of intratumoral heterogeneity in human ovarian cancer
    Choi, Yoon Pyo
    Shim, Hyo Sup
    Gao, Ming-Qing
    Kang, Suki
    Cho, Nam Hoon
    CANCER LETTERS, 2011, 307 (01) : 62 - 71
  • [6] Molecular landscape of borderline ovarian tumours: A systematic review
    Sadlecki, Pawel
    Walentowicz-Sadlecka, Malgorzata
    OPEN MEDICINE, 2024, 19 (01):
  • [7] Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer
    Bischof, A
    Briese, V
    Richter, DU
    Bergemann, C
    Friese, K
    Jeschke, U
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1639 - 1644
  • [8] The ultrasound features of papillary projections in benign, borderline and malignant ovarian tumours
    Mitchell, Sian
    Abdelbar, Ahmed
    Mehra, Gautam
    Sayasneh, Ahmad
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A410 - A410
  • [9] SOMATIC MOLECULAR GENETIC HETEROGENEITY OF AVMs
    Daboub, F.
    Grimmer, J. F.
    Frigerio, A.
    Wooderchack, D. W.
    Bayrak, P. T.
    Carey, J. C.
    Longo, N.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2020, 182 (04) : 938 - 939
  • [10] Molecular pathogenesis of borderline and invasive ovarian tumors
    Stanojevic, Z.
    Djordjevic, B.
    Pajovic, S. B.
    Zivanov-Curlis, J.
    Najman, S.
    JOURNAL OF BUON, 2009, 14 (01): : 7 - 18